| Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy. D Papahadjopoulos, TM Allen, A Gabizon, E Mayhew, K Matthay, ... Proceedings of the National Academy of Sciences 88 (24), 11460-11464, 1991 | 2192 | 1991 |
| Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomes A Gabizon, R Catane, B Uziely, B Kaufman, T Safra, R Cohen, F Martin, ... Cancer research 54 (4), 987-992, 1994 | 1856 | 1994 |
| Pharmacokinetics of pegylated liposomal Doxorubicin: review of animal and human studies A Gabizon, H Shmeeda, Y Barenholz Clinical pharmacokinetics 42, 419-436, 2003 | 1839 | 2003 |
| Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors. A Gabizon, D Papahadjopoulos Proceedings of the National Academy of Sciences 85 (18), 6949-6953, 1988 | 1618 | 1988 |
| Challenges and key considerations of the enhanced permeability and retention effect for nanomedicine drug delivery in oncology U Prabhakar, H Maeda, RK Jain, EM Sevick-Muraca, W Zamboni, ... Cancer research 73 (8), 2412-2417, 2013 | 1558 | 2013 |
| Sterically stabilized liposomes: a hypothesis on the molecular origin of the extended circulation times DD Lasic, FJ Martin, A Gabizon, SK Huang, D Papahadjopoulos Biochimica et Biophysica Acta (BBA)-Biomembranes 1070 (1), 187-192, 1991 | 773 | 1991 |
| Pegylated liposomal doxorubicin (doxil): reduced clinical cardiotoxicity in patients reaching or exceeding cumulative doses of 500 mg/m2 T Safra, F Muggia, S Jeffers, DD Tsao-Wei, S Groshen, O Lyass, ... Annals of Oncology 11 (8), 1029-1034, 2000 | 740 | 2000 |
| Pegylated liposomal doxorubicin: metamorphosis of an old drug into a new form of chemotherapy AA Gabizon Cancer investigation 19 (4), 424-436, 2001 | 686 | 2001 |
| Polyethylene glycol-coated (pegylated) liposomal doxorubicin: rationale for use in solid tumours A Gabizon, F Martin Drugs 54 (Suppl 4), 15-21, 1997 | 644 | 1997 |
| Tumor cell targeting of liposome-entrapped drugs with phospholipid-anchored folic acid–PEG conjugates A Gabizon, H Shmeeda, AT Horowitz, S Zalipsky Advanced drug delivery reviews 56 (8), 1177-1192, 2004 | 637 | 2004 |
| Selective tumor localization and improved therapeutic index of anthracyclines encapsulated in long-circulating liposomes AA Gabizon Cancer research 52 (4), 891-896, 1992 | 586 | 1992 |
| Targeting folate receptor with folate linked to extremities of poly (ethylene glycol)-grafted liposomes: in vitro studies A Gabizon, AT Horowitz, D Goren, D Tzemach, F Mandelbaum-Shavit, ... Bioconjugate chemistry 10 (2), 289-298, 1999 | 585 | 1999 |
| Liposomal doxorubicin: antitumor activity and unique toxicities during two complementary phase I studies. B Uziely, S Jeffers, R Isacson, K Kutsch, D Wei-Tsao, Z Yehoshua, ... Journal of Clinical Oncology 13 (7), 1777-1785, 1995 | 571 | 1995 |
| Nuclear delivery of doxorubicin via folate-targeted liposomes with bypass of multidrug-resistance efflux pump D Goren, AT Horowitz, D Tzemach, M Tarshish, S Zalipsky, A Gabizon Clinical Cancer Research 6 (5), 1949-1957, 2000 | 551 | 2000 |
| Activation of complement by therapeutic liposomes and other lipid excipient-based therapeutic products: prediction and prevention J Szebeni, F Muggia, A Gabizon, Y Barenholz Advanced drug delivery reviews 63 (12), 1020-1030, 2011 | 486 | 2011 |
| Correlation of toxicity with pharmacokinetics of pegylated liposomal doxorubicin (Doxil) in metastatic breast carcinoma O Lyass, B Uziely, R Ben‐Yosef, D Tzemach, NI Heshing, M Lotem, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 2000 | 452 | 2000 |
| Liposomes as in Vivo Carriers of Adriamycin: Reduced Cardiac Uptake and Preserved Antitumor Activity in Mice A Gabizon, A Dagan, D Goren, Y Barenholz, Z Fuks Cancer research 42 (11), 4734-4739, 1982 | 401 | 1982 |
| In vivo fate of folate-targeted polyethylene-glycol liposomes in tumor-bearing mice A Gabizon, AT Horowitz, D Goren, D Tzemach, H Shmeeda, S Zalipsky Clinical cancer research 9 (17), 6551-6559, 2003 | 391 | 2003 |
| The role of surface charge and hydrophilic groups on liposome clearance in vivo A Gabizon, D Papahadjopoulos Biochimica Et Biophysica Acta (BBA)-Biomembranes 1103 (1), 94-100, 1992 | 375 | 1992 |
| Ultrasound triggered release of cisplatin from liposomes in murine tumors A Schroeder, R Honen, K Turjeman, A Gabizon, J Kost, Y Barenholz Journal of controlled release 137 (1), 63-68, 2009 | 359 | 2009 |
